Which is better, BIOA or MTD?

On the Buffett-Fit framework, Mettler-Toledo International Inc. (MTD) currently grades higher than BIOA — 69/100 (B grade) vs 42/100 (D). That said, "better" depends on which framework you trust — BIOA wins on Philip Fisher; MTD wins on Warren Buffett, Benjamin Graham, Peter Lynch, Joel Greenblatt, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy BIOA or MTD?

This page is an educational comparison, not investment advice. Both BIOA and MTD are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is BIOA better than MTD for value investing?

On the Buffett-style value-investing framework, MTD currently grades higher — 69/100 vs 42/100, a 27-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between BIOA and MTD on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). BIOA currently scores 42/100 (D grade); MTD scores 69/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, BIOA or MTD?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. BIOA and MTD are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, BIOA or MTD?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are BIOA and MTD both Healthcare stocks?

Yes — both BioAge Labs, Inc. (BIOA) and Mettler-Toledo International Inc. (MTD) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this BIOA vs MTD comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

BioAge Labs

Mettler-Toledo International

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

BIOA

BioAge Labs

Market cap

$625.36M

Sector

Healthcare

MTD

Mettler-Toledo International

Market cap

$22.29B

Sector

Healthcare

Overall winner

Mettler-Toledo International MTD

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	BIOA	MTD	Winner
Warren Buffett	42D	69B	MTD
Benjamin Graham	42D	65B	MTD
Philip Fisher

Side-by-side metrics

Metric	BIOA	MTD
Market cap	$625.36M	$22.29B
P/E (TTM)	-	25.3x
EV/EBIT	-	21.6x
ROIC (TTM)	-26.51%	36.09%
Gross margin	99.39%	57.79%
Net margin	-8.72%	21.4%
Revenue CAGR 5y	-

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

BIOA leads on

P/E (TTM)-vs 25.3x+131%
EV/EBIT-vs 21.6x+119%
Gross margin99.39%vs 57.79%+42%

MTD leads on

More like BIOA

BIOA vs HALO BIOA vs LMAT BIOA vs RMD BIOA vs LLY BIOA vs UTHR BIOA vs HAE

More like MTD

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.